Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA9 | Q16790 | 11/20 | 0.80 |
| ▸ | CA12 | O43570 | 10/20 | 0.80 |
| ▸ | CA1 | P00915 | 7/20 | 0.80 |
| ▸ | CA4 | P22748 | 4/20 | 0.80 |
| ▸ | CA6 | P23280 | 3/20 | 0.80 |
| ▸ | CA7 | P43166 | 3/20 | 0.80 |
| ▸ | CA14 | Q9ULX7 | 3/20 | 0.80 |
| ▸ | CA5B | Q9Y2D0 | 3/20 | 0.80 |
| ▸ | CA2 | P00918 | 2/20 | 0.80 |
| ▸ | CA3 | P07451 | 1/20 | 0.80 |
| ▸ | CA5A | P35218 | 2/20 | 0.70 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.64 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.60 |
| ▸ | MAOA | P21397 | 4/20 | 0.56 |
| ▸ | MAOB | P27338 | 4/20 | 0.56 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.53 |
| ▸ | MTNR1A | P48039 | 1/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14802544 | 0.97 | CA9 (0.76) | CA9CA12CA1CA4CA6 | |
| SCHEMBL14802620 | 0.96 | CA9 (0.74) | CA9CA12CA1CA4CA6 | |
| SCHEMBL27950165 | 0.94 | CA9 (0.80) | CA9CA12CA1CA4CA6 | |
| 7-Butoxycoumarin SCHEMBL6686295 | 0.89 | CA12 (1.00) | CA9CA12CA1CA4CA6 | |
| SCHEMBL11036182 | 0.87 | CA9 (0.79) | CA9CA12CA1CA4CA6 | |
| SCHEMBL29772322 | 0.86 | CA12 (0.68) | CA9CA12CA1CA4CA6 | |
| SCHEMBL14634620 | 0.86 | CA12 (0.68) | CA9CA12CA1CA4CA6 | |
| SCHEMBL14329518 | 0.86 | CA12 (0.94) | CA9CA12CA1CA4CA6 | |
| SCHEMBL15591954 | 0.85 | CA12 (0.91) | CA9CA12CA1CA4CA6 | |
| SCHEMBL14329530 | 0.85 | CA12 (0.91) | CA9CA12CA1CA4CA6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7842822-B2 | Substituted benzopyrans as selective estrogen receptor-beta agonists | ELI LILLY AND COMPANY (US) | 2010-11-30 | — | — | US | disclosed |
| US-20090298925-A1 | SUBSTITUTED BENZOPYRANS AS SELECTIVE ESTROGEN RECEPTOR-BETA AGONISTS | DURST GREGORY LEE | 2009-12-03 | — | — | US | disclosed |
| US-7585985-B2 | Substituted benzopyrans as selective estrogen receptor-beta agonists | ELI LILLY AND COMPANY (US) | 2009-09-08 | — | — | US | disclosed |
| US-20080312312-A1 | SUBSTITUTED BENZOPYRANS AS SELECTIVE ESTROGEN RECEPTOR-BETA AGONISTS | DURST GREGORY LEE | 2008-12-18 | — | — | US | disclosed |
| US-7442812-B2 | Substituted benzopyrans as selective estrogen receptor-beta agonists | ELI LILLY AND COMPANY (US) | 2008-10-28 | — | — | US | disclosed |
| EP-1626974-B1 | SUBSTITUTED BENZOPYRANS AS SELECTIVE ESTROGEN RECEPTOR-BETA AGONISTS | LILLY CO ELI (US) | 2008-08-27 | — | — | EP | disclosed |
| US-20070106082-A1 | Substituted benzopyrans as selective estrogen receptor-beta agonists | ELI LILLY AND COMPANY | 2007-05-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070106082-A1 | Substituted benzopyrans as selective estrogen receptor-beta agonists | MCHR1, MCHR2, MC1R | CA9 4007/4885CA12 4278/4885CA1 4627/4885 |
| US-20090298925-A1 | SUBSTITUTED BENZOPYRANS AS SELECTIVE ESTROGEN RECEPTOR-BETA AGONISTS | GPER1, ESR2, ESR1 | CA9 3586/4885CA12 4151/4885CA1 4610/4885 |
| US-20080312312-A1 | SUBSTITUTED BENZOPYRANS AS SELECTIVE ESTROGEN RECEPTOR-BETA AGONISTS | GPER1, ESR2, ESR1 | CA9 3586/4885CA12 4151/4885CA1 4610/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.